Clinical Trials · NCT00433160
Phase 3 Clinical Trial of Teriparatide in Japan
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 207
- Start date
- Jan 2007
- Locations
- 16 sites, Japan
- Primary endpoint
- Percent Change in Bone Mineral Density at Lumbar Spine (L2-L4)